Download presentation
1
Rheumatology: Back to Basics: 2016
James Gillray “The Gout” 1799
3
Immune Mechanisms of Disease
Type I: Anaphylactic IgE eg. asthma Type II: Cytotoxic eg. AIHA Type III: Immune Complex eg. SLE Type IV: Cell-mediated/Delayed Hypersensitivity: T-cells eg. Contact dermatitis
4
GENETICS ENVIRONMENT Infections... AUTOIMMUNITY
5
HLA: Disease Associations
HLA B27 (MHC Class I) - Ankylosing Spondylitis Reiter’s/reactive arthritis - Psoriatic arthritis - IBD arthropathy HLA DR4, DR1 (MHC Class II) - RA HLA DR3 (MHC Class II) - SLE, Sjogren’s, Type I DM…
6
We love our antibodies...
7
Rheumatoid Factor Rheumatoid Arthritis: - sensitivity = 70%
Anti-antibodies (Fc domain of IgG) Rheumatoid Arthritis: - sensitivity = 70% - poor prognosis - extra-articular features Non-specific: - other rheumatic diseases eg. Sjogren’s - chronic inflammatory diseases - chronic infections – SBE, Hep C % over age 65
8
Anti-Citrullinated Peptide Antibodies (CCP or ACPA)
More specific for RA More sensitive than RF in early RA Associated with worse prognosis
9
Antinuclear Antibodies
Sensitivity for SLE 90%+ Specificity low - other autoimmune diseases - family members - drugs - ...
10
Raynaud’s phenomenon Cold, stress 3 phases: white blue red
5 % of normals 90% - scleroderma Consider ANA when screening (SLE, CREST)
11
ANA: Anti-centromere pattern: Limited Systemic Sclerosis (CREST)
12
Other Autoantibodies Anti-DNA (native, double-stranded)
- SLE- sensitivity 60-70% - specificity ~ 100% - correlate with disease activity Anti-SSA, SSB (Ro, La) - Sjogren’s, SLE - congenital complete heart block
13
Antibodies to Ro/SSA 30-35% of patients with Lupus Associated with:
- Sjogren’s syndrome - photosensitive rashes “subacute cutaneous lupus” - Neonatal lupus - transient rashes - congenital complete heart block
14
Adult: Subacute Newborn: Cutaneous Lupus Neonatal Lupus
Antibodies to Ro/SSA Adult: Subacute Newborn: Cutaneous Lupus Neonatal Lupus
15
Antiphospholipid Antibodies
Anticardiolipin antibodies Lupus anticoagulant Anti -2 GPI Associations: - thrombosis - recurrent pregnancy losses SLE, other CTD’s, primary
16
Anti-Neutrophil Cytoplasmic Antibodies (ANCA)
Patients with suspected vasculitis: - Granulomatosus with polyangiitis (GPA) Wegener’s - pulmonary/renal - RPGN - cocaine Cytoplasmic Perinuclear
17
Anti-Neutrophil Cytoplasmic Antibodies (ANCA)
Patients with suspected vasculitis - pulmonary/renal syndromes cANCA: Granulomatosus with polyangiitis (GPA) Wegener’s: - 80% sensitive and specific - specificity is for PR-3 pANCA: less specific
18
Specific Diseases…
19
Osteoarthritis (OA) The most common type of arthritis
Disease of cartilage (cf. RA) Characterized by: - Cartilage degradation, loss - hypertrophic bone formation (osteophytes...
20
Primary (idiopathic) OA
Peripheral Joints: - hands - DIP, PIP (cf. RA) - 1st C-MC - feet - 1st MTP - large weight-bearing joints - hips, knees Spine - apophyseal joints - intervertebral discs
21
OA: Heberden’s (DIP) Bouchard’s (PIP) Nodes
22
Osteoarthritis: X-ray 1st C-MC Joint
Joint space narrowing Subchondral sclerosis Osteophytes
23
Rheumatoid Arthritis Prevalence 1:100
small joint, symmetric polyarthritis + AM stiffness chronic (>6weeks) Path = synovial inflammation Extra-articular features
24
DIPs (spared) PIPs MCPs
25
Rheumatoid Arthritis Deformities Nodules Periarticular osteopenia
Marginal erosions
26
RA: Extra-articular Features
Skin - sc nodules, vasculitis... Eyes - sicca, scleritis, episcleritis Lungs - pleurisy/effusion - interstitial fibrosis - nodules Cardiac - pericarditis, nodules Hematologic - anemia, Felty’s (neutropenia…) Neurologic - peripheral neuropathy...
27
Scleritis
28
RA: Nodules
29
RA: Factors Associated with Poor Prognosis
RF, CRP, anti-CCP (ACPA) positivity HLA-DR4 haplotype Degree of disease activity at onset … Early aggressive therapy
30
RA: Treatment Symptomatic - rest, education - splints, orthotics
- ASA, NSAID’s, Coxibs Disease Modifying Anti-Rheumatic Drugs (DMARDs)
31
RA: Common DMARD’s Methotrexate Hydroxychloroquine Sulfasalazine
New Biologics...
32
RA: New Therapies - Biologics
anti-TNF soluble TNF receptor other mechanisms: CTLA4-Ig, IL-6, B-cells… Concerns: - cost - parenteral (most) - risk of infections, TB
34
Systemic Lupus Erythematosus
Affects 1: individuals African American blacks > Asian, hispanics, native NA > Caucasian Females : Males = 9:1 Any age - usually young females in their reproductive years
35
Lupus: Criteria Malar rash Hematology: Photosensitivity anti-WBC
Discoid rash Mucosal ulcers Arthritis Serositis “Pleurisy” Renal CNS Hematology: anti-WBC anti-platelet anti-rbc Immunologic: anti-DNA anti-phospholipid anti-Sm Antinuclear antibodies
36
SLE: Organs Affected Joints: 80-90% Skin: 70%, often photosensitive
Serositis: 50% Kidneys: 25-50% CNS: 15%
37
Discoid Lupus Plaques Photosensitive Often head & neck Scarring
10% develop SLE
38
Lupus: Treatment Sunscreens, sunprotection Anti-inflammatory drugs
Anti-malarial drugs Steroids Immunosuppressants Mycophenolate mofetil
39
Systemic Sclerosis (Scleroderma): Skin thickening, tightening
40
Scleroderma - small blood vessels = SPASM, ischemia +
Disorder of: - small blood vessels = SPASM, ischemia + - overproduction of connective tissue (collagen) = FIBROSIS
41
Scleroderma: Types Systemic - Diffuse
- Limited (CREST) anti-centromere Localized - morphea - linear scleroderma
42
Scleroderma Lungs - fibrosis - Pulmonary hypertension GI - GERD...
Renal - malignant hypertension - microangiopathic anemia - renal failure - ACE Inhibitors!!!!!!!!!!!!!!!
43
Limited Scleroderma (CREST)
Calcinosis Telangiectasias
44
Acute Monoarthritis (in absence of trauma)
Infection Crystal (gout, pseudogout) Spondyloarthropathy
45
Synovial Fluid Testing
Cell count, differential WBC: = non-inflammatory ,000 = inflammatory >75,000 = septic Gram stain, C&S Crystals
46
Spondyloarthropathies
Axial and/or peripheral joints HLA-B27 Path = enthesopathy Inflammatory back pain Extra-articular: - uveitis etc. RF negative Ankylosing Spondylitis Reiter’s/reactive arthritis Psoriatic arthritis Inflammatory Bowel Disease
47
Enthesitis Erosion Calcaneal Spur
Reiter’s - erosion at Achilles insertion into calcaneus and extra bone at site of plantar fasciitis Calcaneal Spur
48
Achilles tendinitis
49
Inflammatory low back pain?
Insidious onset Worse with rest Better with activity Morning stiffness Family history Bilateral Sacroiliitis
50
Ankylosing Spondylitis
51
HLA-B27: Disease Associations
Ankylosing Spondylitis >90% Reiter’s syndrome/ reactive 80% Inflammatory bowel disease 50% Psoriatic Arthritis - with spondylitis 50% - with peripheral arthritis 15% Caucasians % Inuit %
52
Reactive Arthritis: Concept
A sterile inflammatory arthritis - triggered by an infection - at a distant site (GI or GU) - in a genetically susceptible host
53
Bacteria that Trigger Reactive Arthritis
Post-venereal: Chlamydia trachomatis Post-dysenteric: Salmonella Shigella flexneri Yersinia enterocolitica Campylobacter Clostridium difficile
54
HLA-B27: Reactive Arthritis
Campylobacter
55
Spondyloarthropathies: Extra-articular features
Skin: Psoriasis, E. nodosum, pyoderma gangrenosum... Eyes: iritis, conjunctivitis Lungs: apical pulmonary fibrosis Cardiac: aortic insufficiency, conduction abnormalities Neurologic: cauda equina...
57
Reiter’s Syndrome
58
Gout Acute monoarthritis - lasts days - recurrent attacks Uncontrolled hyperuricemia tophi polyarthritis
59
Gout: uric acid crystals
Needle-shaped Strong negative bireringence Phagocytosed by PMN’s
60
Gout: Treatment Asymptomatic hyperuricemia none
Acute attack - NSAID’s - colchicine - steroid’s Indications to lower uric acid – allopurinol, febuxistat - renal stones - frequent attacks - tophi
61
Pseudogout - CPPD Acute monoarthritis Knees, wrists Chondrocalcinosis
Pyrophosphate crystals: - rhomboid - weak positive birefringence
62
Vasculitis: Classification NB! can have overlap...
1. Large Vessel Vasculitis 2. Medium Vessel Vasculitis 3. Small Vessel Vasculitis
63
Large Vessel Vasculitis
- Giant Cell Arteritis - Takayasu’s (Aortic Arch Syndrome)
64
Medium Vessel Vasculitis
- Polyarteritis nodosa (PAN) - Kawasaki Disease - Primary CNS Vasculitis
65
Small Vessel Vasculitis
Palpable purpura Most common vasculitis Leukocytoclastic vasculitis Ag (eg. Infection, drug) + Ab immune complex Rule out other organ involvement (kidney, lung…)
66
Small Vessel Vasculitis
- ANCA Associated: - Wegener Granulomatosis - Churg-Strauss Syndrome - Microscopic Polyangiitis (MPA) - Henoch-Schönlein Purpura (HSP) - Vasculitis with connective tissue diseases - Vasculitis/essential mixed cryoglobulinemia (Hep C) - Hypersensitivity vasculitis (leukocytoclastic) - Vasculitis with viral infections (Hep B, C, HIV, CMV, parvo-B19)
67
Small Vessel Vasculitis: ANCA associated: e.g. GPA Wegener’s
Small + medium vessels Granulomatous Upper +/- lower respiratory (ulcers, sinuses...) Renal
68
Anti-Neutrophil Cytoplasmic Antibodies (ANCA)
Patients with suspected vasculitis: Pulmonary - renal: - GPA/Wegeners - ... Cytoplasmic Perinuclear
69
ANCA Immunofluorescence cytoplasmic - cANCA perinuclear - pANCA
Solid Phase Assays (ELISA…) : pANCA = anti-MPO (myeloperoxidase) cANCA = anti-PR3 (proteinase 3)
70
cANCA (anti-PR3) Highly sensitive, specific for Wegener’s granulomatosis Specificity: 95%
71
Large Vessel Vasculitis Giant Cell (Temporal) Arteritis
72
Large Vessel Vasculitis Giant Cell Arteritis (GCA)
Age >50 years - mean = 70 years Symptoms related to arteries: - headache, scalp tenderness - visual loss - jaw claudication
73
Giant Cell (Temporal) Arteritis
Diagnosis: - CBC - anemia of chronic disease - ESR - markedly elevated, often >100 - Biopsy temporal artery Treatment: URGENT! (prevent visual loss) - steroids - prednisone 60mg daily...
74
Fibromyalgia Prevalence 3% widespread pain, tender points
sleep disturbance Absence of inflammatory markers… Exclusion of other systemic disorders Treatment: - education - exercise - low dose tricyclic - New = pregabalin, duloxetine Canadian Guidelines
76
NSAIDs, Coxibs
77
Toxicity: ASA and NSAIDs
GI: ulcers, bleeding CVS: hypertension, increased risk MI, stroke Renal: Na retention, edema, renal failure CNS anti platelet effects contraindicated ASA hypersensitivity avoid if possible - pregnancy and lactation
78
Cox-2 “specific” Inhibitors (coxibs)
improved GI safety no effect on platelets efficacious in RA, OA, pain CVS, renal effects like other NSAID’s caution! - elderly hypertension - cardiac disease - renal disease
79
The diaper is full so this must be…
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.